The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...

Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...

Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.

OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...

The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...

ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...

Top Deals on ResMed CPAP Machines and Masks As an official distributor of ResMed products, Air Voel is offering exceptional deals on their top-rated CPAP machines and masks. ResMed's innovative ...

ResMed is a leading manufacturer of Continuous Positive Airway Pressure (CPAP) devices ... which is at the moment the gold standard, is a mask that keeps the airway open. It does not require ...

Read more. ResMed CPAP masks subject to Class I recall over magnetic interference issue Six reported injuries related to magnets on the headgear of CPAP machines by ResMed Ltd. have resulted in a ...

The best LED face masks are well designed, feature an effective number of LED bulbs and make it easy to complement a tailored skincare routine when used properly and consistently. After ...